Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Frankfurt - Delayed Quote EUR

West Pharmaceutical Services, Inc. (WPS.F)

Compare
196.75
-1.05
(-0.53%)
As of 8:24:09 AM GMT+2. Market Open.
Loading Chart for WPS.F
  • Previous Close 197.80
  • Open 196.75
  • Bid 195.00 x 10000
  • Ask 201.00 x 10000
  • Day's Range 196.75 - 196.75
  • 52 Week Range 192.15 - 362.60
  • Volume 30
  • Avg. Volume 33
  • Market Cap (intraday) 14.505B
  • Beta (5Y Monthly) 1.22
  • PE Ratio (TTM) 32.10
  • EPS (TTM) 6.13
  • Earnings Date Apr 23, 2025 - Apr 28, 2025
  • Forward Dividend & Yield 0.81 (0.41%)
  • Ex-Dividend Date Apr 30, 2025
  • 1y Target Est --

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

www.westpharma.com

10,600

Full Time Employees

December 31

Fiscal Year Ends

Recent News: WPS.F

View More

Performance Overview: WPS.F

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

WPS.F
37.83%
S&P 500 (^GSPC)
8.25%

1-Year Return

WPS.F
44.38%
S&P 500 (^GSPC)
4.84%

3-Year Return

WPS.F
47.26%
S&P 500 (^GSPC)
17.76%

5-Year Return

WPS.F
41.40%
S&P 500 (^GSPC)
116.85%

Compare To: WPS.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: WPS.F

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    14.58B

  • Enterprise Value

    14.42B

  • Trailing P/E

    32.24

  • Forward P/E

    35.46

  • PEG Ratio (5yr expected)

    3.69

  • Price/Sales (ttm)

    5.49

  • Price/Book (mrq)

    5.81

  • Enterprise Value/Revenue

    5.43

  • Enterprise Value/EBITDA

    21.13

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    17.03%

  • Return on Assets (ttm)

    9.93%

  • Return on Equity (ttm)

    17.71%

  • Revenue (ttm)

    2.89B

  • Net Income Avi to Common (ttm)

    492.7M

  • Diluted EPS (ttm)

    6.13

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    484.6M

  • Total Debt/Equity (mrq)

    11.38%

  • Levered Free Cash Flow (ttm)

    206.72M

Research Analysis: WPS.F

View More

Company Insights: WPS.F

Research Reports: WPS.F

View More

People Also Watch